Protein kinase inhibitors
    1.
    发明授权
    Protein kinase inhibitors 有权
    蛋白激酶抑制剂

    公开(公告)号:US08859553B2

    公开(公告)日:2014-10-14

    申请号:US13561960

    申请日:2012-07-30

    IPC分类号: A61K31/525 A61K31/501

    摘要: The present invention relates to compounds of Formula I: as well as pharmaceutically acceptable salts, hydrates, isomers, or solvates thereof, wherein the variables are described herein. The present invention further relates to pharmaceutical compositions which comprise the compounds of Formula I, and to methods for inhibiting protein kinase and methods of treating diseases, such as cancers, inflammation.

    摘要翻译: 本发明涉及式I化合物及其药学上可接受的盐,水合物,异构体或溶剂合物,其中本文描述了变量。 本发明还涉及包含式I化合物的药物组合物,以及用于抑制蛋白激酶的方法和治疗疾病如癌症的方法。